# Intraoperative Continuous Terlipressin Infusion is Associated With Reduced Severe Postoperative Complications After Laparoscopic Hepatectomy: a Prospective Propensity Score-matched Cohort Study

> **NCT07719933** · — · COMPLETED · sponsor: **First Affiliated Hospital, Sun Yat-Sen University** · enrollment: 161 (actual)

## Conditions studied

- Liver Neoplasms
- Postoperative Complications

## Interventions

- **DRUG:** terlipressin

## Key facts

- **NCT ID:** NCT07719933
- **Lead sponsor:** First Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-05-14
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2026-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07719933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07719933, "Intraoperative Continuous Terlipressin Infusion is Associated With Reduced Severe Postoperative Complications After Laparoscopic Hepatectomy: a Prospective Propensity Score-matched Cohort Study". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07719933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*